THERAPEUTICSMD INC - COM (TXMD)

CUSIP: 88338N107

Q2 2019 13F Holders as of 30 Jun 2019

Type / Class
Equity / COM
Total 13F shares
188,901,090
Share change
+669,942
Total reported value
$489,428,303
Put/Call ratio
234%
Price per share
$2.60
Number of holders
144
Value change
-$20,791,317
Number of buys
79
Number of sells
45

Quarterly Holders Quick Answers

What is CUSIP 88338N107?
CUSIP 88338N107 identifies TXMD - THERAPEUTICSMD INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of THERAPEUTICSMD INC - COM (TXMD) as of Q2 2019

As of 30 Jun 2019, THERAPEUTICSMD INC - COM (TXMD) was held by 144 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 188,901,090 shares. The largest 10 holders included PRICE T ROWE ASSOCIATES INC /MD/, Bank of New York Mellon Corp, FMR LLC, JPMORGAN CHASE & CO, BlackRock Inc., VANGUARD GROUP INC, FRANKLIN RESOURCES INC, Rubric Capital Management LP, FRONTIER CAPITAL MANAGEMENT CO LLC, and STATE STREET CORP. This page lists 144 institutional shareholders reporting positions in this security for the Q2 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.